Skip to main content
. 2022 Mar 3;36(2):907–917. doi: 10.21873/invivo.12780

Figure 5. Changes in the IBPS after nivolumab administration according to Glasgow Prognostic Score (GPS), neutrophil-to-lymphocyte ratio (NLR), C-reactive protein (CRP)-to-albumin ratio (CAR), platelet-to-lymphocyte ratio (PLR) and eosinophil (EOS) count. m: Months.

Figure 5